The effect of biologics on postoperative complications in children with inflammatory bowel disease and bowel resection

Medicine and Dentistry

• Abdominal Abscess 40%
• Abdominal Wall 20%
• Abscess 20%
• Adalimumab 20%
• Adult 20%
• Analysis 20%
• Biological Product 100%
• Bowel Resection 100%
• Child 80%
• Combination Therapy 40%
• Complication 100%
• Crohn's Disease 20%
• Diagnosis 20%
• Incidence 20%
• Inflammatory Bowel Disease 80%
• Infliximab 20%
• Inpatient 20%
• Medication 20%
• Patient 60%
• Patient with Inflammatory Bowel Disease 20%
• Pediatrics 20%
• Pediatrics Patient 20%
• Postoperative Complication 80%
• Pouchitis 20%
• Skin Infection 20%
• Surgery 100%
• Ulcerative Colitis 20%
• Vedolizumab 20%
• Wound Dehiscence 20%